Monday, December 04, 2023 12:52:06 PM
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million launched
X 4. In house marketing and distribution: Kirkov
--5. Generic OxyContin- FIRST TO FILE Aug 17, 2023 $720 Million
X 6. DEA increases manufacturing quotas of Adderall & Vyvance
X 7. Double digit quarterly revenues in millions.
—8. Full ownership of Adderall IR $ 335 Million LAUNCHED
—9. Full ownership of Adderall XR $ 1.56 Billion LAUNCHED
—10. Generic Concerta- $1.2 BILLION
—11. Generic Vyvanse- $5.3 BILLION
—12. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
—13. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
—14. Patented Unique ADF (w/o naltrexone)-- NDA
—15. Mikah ANDA (s)
—16. Undisclosed (s)
—17. Antimetabolite ANDA- Methotrexate -$600 Million
—18. Undisclosed Antimetabolite ANDA- $42 Million
X 19. Prasco/Burel Adderall agreement January 1st 2024
—20. Triple digit yearly revenues in millions.
—21. European distribution Dexcel partnership approval by Israeli Health
—22. Purchase or rent additional manufacturing space for new ANDAs
—23. Uplist to the NASDAQ Exchange
—24. THE Buy Out !
—25. Vegas Baby !!!!!!!
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM